Filobasidium magnum (Lodder et Kreger-van Rij) Liu et al.
商品貨號
B189839
Strain Designations
MF 1223/07 [CBS 11699]
Biosafety Level
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
frozen
Storage Conditions
Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section
Type Strain
no
Preceptrol®
no
Comments
Clinical isolate
Resistant to caspofungin, anidulafungin, 5-flucytosine and itroconazole.
Susceptible to amphotericin-B, posaconazole and voriconazole.
Morphology
On YM medium colonies are cream colored to tan with a smooth, glossy and slimy texture; the margin is entire. Cells spheroidal to ovoidal to elongate, single, in pairs or short chains.? Small amount of sediment is formed.
Medium
ATCC® Medium 28: Emmons' modification of Sabouraud's agar
ATCC® Medium 200: YM agar or YM broth
ATCC® Medium 25: Yeast extract-glucose medium
Nasal swab culture from leukemia patient, Cancer hospital, Kuwait. May, 2007
Cross References
Nucleotide (GenBank) :
JQ070136
D1/D2 region of 28S rRNA gene
Nucleotide (GenBank) :
JQ070110
ITS including 5.8S rRNA gene
References
Khan Z, et al. Isolation of Cryptococcus magnus and Cryptococcus chernovii from nasal cavities of pediatric patients with acute lymphoblastic leukemia. Med. Mycol. 49(4): 439-443, 2011. PubMed: 20979444
